Ipca Laboratories Q1 FY27 Results (NSE: IPCALAB)

· Analysis by Alpha Inflection

Signal: Margin expansion

Ipca Laboratories Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹2,788.1 Cr+20.8%+16.7%
Net profit₹401.89 Cr+72.3%
EPS₹15.84+72.4%
EBIT margin22.88%

P&L walk

Consolidated revenue rose to ₹2,788.10 crore, up 20.8% YoY and 16.7% QoQ, while EBITDA margin expanded to 22.88% from 18.39% and PAT attributable to owners increased 72.3% to ₹401.89 crore, helped by operating margin expansion and higher subsidiary contribution.

View original filing

Research and educational content only. Not investment advice.